Vertex said a drug it secured as part of a $4.9 billion acquisition successfully reduced by half a key marker of a kidney disease known as IgA nephropathy.

A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.

Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news ...

Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug Wegovy.

There is growing concern that the FDA is shunning advisory committees that allow agency leaders, drugmakers, patients, and doctors to speak their minds in public ...

Fresh turmoil at the FDA with Prasad’s exit. Vinay Prasad is out at the Food and Drug Administration for the second time during the Trump administration, after a tumultuous reig ...

Universal Health Services, a behavioral health provider that operates over 340 inpatient facilities across 40 states, announced Monday that it will ...

Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.

A new data analysis from Blue Cross Blue Shield shows how AI coding may be driving up the cost of health care.

The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more transparency.

Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.

How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.